Biogen and Ionis see 2016 U.S. launch for SMA med

Biogen ($BIIB) and drug partner Ionis ($IONS) posted more positive data from another late-stage trial for nusinersen, now known as Spinraza, for the rare but devastating fatal childhood disease spi | Biogen and drug partner Ionis posted more positive data from another late-stage trial for nusinerse…